Spirolactone for inhibiting the cardiotoxic effects of adriamycin

摘要

The administration of aldosterone inhibitors of the spirolactone structural type prior to and during treatment with anti- neoplastic agents such as adriamycin results in retention of the desired activity of the latter substances while inhibiting their undesirable cardiotoxic properties.